Current Pharmaceutical Trends in Neuroimmunology – Part II: Autoimmunity Beyond
the CNS and Other Disorders

Paulus   S.   Rommer; Uwe   K.   Zettl

[1] 
Rommer PS, Zettl UK. Current Pharmaceutical Trends in Neuroimmunology - Part I: Disorders Affecting the CNS. Curr Pharm Des  2022; 28(6): 427.
[2] 
Svačina MKR, Lehmann HC. Chronic inflammatory demyelinating polyneuropathy (CIDP): current therapies and future approaches. Curr Pharm Des  2022; 28(11): 854-62.
[3] 
Glaubitz S, Zeng R, Rakocevic G, Schmidt J. Update on Myositis Therapy: from Today’s Standards to Tomorrow’s Possibilities. Curr Pharm Des  2022; 28(11): 863-80.
[4] 
Mrak D, Bonelli M, Radner H. Neuropsychiatric systemic lupus erythematosus: a remaining challenge. Curr Pharm Des  2022; 28(11): 881-91.
[5] 
Brakemeier S, Stolte B, Kleinschnitz C, Hagenacker T. Treatment of adult spinal muscular atrophy: overview and recent developments. Curr Pharm Des  2022; 28(11): 892-8.

Rights & Permissions Print Export Cite as

Article Metrics

16

1

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/138161282811220531104017	Print ISSN 1381-6128
Publisher Name Bentham Science Publisher	Online ISSN 1873-4286

Current Pharmaceutical Design

Current Pharmaceutical Trends in Neuroimmunology – Part II: Autoimmunity Beyond the CNS and Other Disorders

Related Journals

Related Books